Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 64.06% vs 107.73% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 76.02% vs 66.76% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 105.98% vs 19.30% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 0.00% vs -2.70% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Mirum Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 14.52% vs 12.27% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 64.06% vs 107.73% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 59.86% vs 38.24% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 76.02% vs 66.76% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 112.09% vs 50.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 105.98% vs 19.30% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.00% vs -2.70% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






